Related Experiment Video
Updated: Dec 6, 2025

Field-Deployable Candidatus Liberibacter asiaticus Detection Using Recombinase Polymerase Amplification Combined with CRISPR-Cas12a
Published on: December 23, 2022
Clascoterone: First Approval
1Springer Nature, Mairangi Bay, Private Bag 65901, Auckland, 0754, New Zealand. dru@adis.com.
Clascoterone (Winlevi®) is a new topical androgen receptor inhibitor approved for acne vulgaris. It targets androgen action in the skin, offering a novel treatment for this common skin condition.
Area of Science:
- Dermatology
- Endocrinology
- Pharmacology
Background:
- Clascoterone is an androgen receptor inhibitor developed for androgen-dependent skin conditions.
- It is formulated as a topical cream and solution by Cassiopea.
- Androgenetic alopecia and acne vulgaris are target indications.
Purpose of the Study:
- To summarize the development milestones of clascoterone.
- To highlight the first approval of clascoterone cream 1% for acne vulgaris.
Main Methods:
- Review of clascoterone development and clinical studies.
- Focus on the mechanism of action in acne vulgaris treatment.
Main Results:
- Clascoterone cream 1% approved in the USA in August 2020 for acne vulgaris in patients 12 years and older.
- Clinical studies for androgenetic alopecia are ongoing with a different formulation.
Conclusions:
- Clascoterone represents a significant advancement in topical acne treatment.
- The drug's mechanism involves inhibiting androgen signaling in sebaceous glands and hair follicles.
More Related Videos
06:14Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients
Published on: October 15, 2017
04:09Endoscopic Injection Sclerotherapy Assisted by Cyanoacrylate and Clips for Gastroesophageal Varices
Published on: June 13, 2025
Related Concept Videos
FDA Approved Drugs: Changes to Approved Drugs
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...